TESARO INC's ticker is TSRO and the CUSIP is 881569107. A total of 208 filers reported holding TESARO INC in Q2 2018. The put-call ratio across all filers is 0.90 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2018 | $3,032,520,000 | -78.3% | 40,842 | -88.6% | 0.00% | -70.0% |
Q3 2018 | $13,959,183,000 | -16.7% | 357,836 | -5.1% | 0.01% | -23.1% |
Q2 2018 | $16,760,875,000 | -13.8% | 376,903 | +10.8% | 0.01% | -13.3% |
Q1 2018 | $19,436,627,000 | -32.1% | 340,158 | -1.5% | 0.02% | -37.5% |
Q4 2017 | $28,615,426,000 | -26.0% | 345,305 | +15.3% | 0.02% | -31.4% |
Q3 2017 | $38,652,154,000 | -4.7% | 299,397 | +3.3% | 0.04% | -10.3% |
Q2 2017 | $40,552,267,000 | +42.8% | 289,949 | +57.1% | 0.04% | +34.5% |
Q1 2017 | $28,392,092,000 | +96983.6% | 184,520 | -15.2% | 0.03% | -12.1% |
Q4 2016 | $29,245,000 | +26.2% | 217,471 | -6.0% | 0.03% | +32.0% |
Q3 2016 | $23,179,000 | +106.4% | 231,239 | +73.1% | 0.02% | +92.3% |
Q2 2016 | $11,231,000 | +2304.9% | 133,620 | +1159.7% | 0.01% | +1200.0% |
Q1 2016 | $467,000 | -55.2% | 10,607 | -46.7% | 0.00% | 0.0% |
Q4 2015 | $1,042,000 | +128.0% | 19,916 | +74.6% | 0.00% | 0.0% |
Q3 2015 | $457,000 | -31.9% | 11,407 | 0.0% | 0.00% | 0.0% |
Q2 2015 | $671,000 | +19.2% | 11,407 | +16.3% | 0.00% | 0.0% |
Q1 2015 | $563,000 | +140.6% | 9,807 | +55.7% | 0.00% | – |
Q4 2014 | $234,000 | – | 6,300 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
INTERWEST VENTURE MANAGEMENT CO | 2,021,403 | $271,838,000 | 64.82% |
NEA Management Company, LLC | 10,275,113 | $1,381,797,000 | 54.94% |
ORACLE INVESTMENT MANAGEMENT INC | 1,248,086 | $167,843,000 | 27.84% |
BLUE JAY CAPITAL MANAGEMENT, LLC | 89,695 | $12,062,000 | 7.28% |
Perceptive Advisors | 687,993 | $92,521,000 | 6.58% |
Avoro Capital Advisors LLC | 231,700 | $31,159,000 | 6.30% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 94,500 | $12,705,000 | 5.72% |
Rock Springs Capital Management LP | 613,500 | $82,503,000 | 5.52% |
SENZAR ASSET MANAGEMENT, LLC | 142,300 | $19,136,000 | 5.08% |
BB BIOTECH AG | 974,582 | $131,062,000 | 4.85% |